There were too few participants with positive TPO antibodies among those with raised TSH to allow a meaningful analysis of the effect of this variable on mortality and cardiovascular outcomes, and too few Aboriginal people to assess the possible consequences of concomitant thyroid disease and type 2 diabetes in this vulnerable sub-group. The gene discussed is TPO; the disease is type 2 diabetes mellitus.